These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23725709)

  • 41. Stereotactic body radiation therapy (stereotactic ablative radiotherapy) for stage I non-small cell lung cancer--updates of radiobiology, techniques, and clinical outcomes.
    Hadziahmetovic M; Loo BW; Timmerman RD; Mayr NA; Wang JZ; Huang Z; Grecula JC; Lo SS
    Discov Med; 2010 May; 9(48):411-7. PubMed ID: 20515609
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Opinions of lung cancer clinicians on shared decision making in early-stage non-small-cell lung cancer.
    Mokhles S; Maat APWM; Aerts JGJV; Nuyttens JJME; Bogers AJJC; Takkenberg JJM
    Interact Cardiovasc Thorac Surg; 2017 Aug; 25(2):278-284. PubMed ID: 28449093
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of Patients With Stage I Lung Cancer.
    Bogart JA; Wallen J
    J Oncol Pract; 2017 Feb; 13(2):69-76. PubMed ID: 28972833
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stereotactic radiosurgery for the treatment of stage I non-small cell lung cancer in high-risk patients.
    Pennathur A; Luketich JD; Heron DE; Abbas G; Burton S; Chen M; Gooding WE; Ozhasoglu C; Landreneau RJ; Christie NA
    J Thorac Cardiovasc Surg; 2009 Mar; 137(3):597-604. PubMed ID: 19258073
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Lung cancer: Stereotactic body radiation therapy and surgery].
    Antoni D; Srour I; Mornex F
    Cancer Radiother; 2015 Oct; 19(6-7):371-6. PubMed ID: 26358983
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stereotactic radiosurgery for lung tumors.
    Whyte RI
    Semin Thorac Cardiovasc Surg; 2010; 22(1):59-66. PubMed ID: 20813318
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stereotactic radiosurgery for lung cancer.
    Banki F; Luketich JD; Chen H; Christie N; Pennathur A
    Minerva Chir; 2009 Dec; 64(6):589-98. PubMed ID: 20029356
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Long-Term Local Control with Radiofrequency Ablation or Radiotherapy for Second, Third, and Fourth Lung Tumors after Lobectomy for Primary Lung Cancer].
    Yokouchi H; Miyazaki M; Miyamoto T; Minami T; Tsuji F; Mikami K; Murata K
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2416-2418. PubMed ID: 28133340
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A review of novel biological tools used in screening for the early detection of lung cancer.
    Ghosal R; Kloer P; Lewis KE
    Postgrad Med J; 2009 Jul; 85(1005):358-63. PubMed ID: 19581246
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [An analysis of 20 consecutive patients treated with stereotactic body radiotherapy on Novalis Tx(®) for stage I non-small-cell lung cancer].
    Guillerme F; Clavier JB; Schumacher C; Falcoz PE; Bourrhala K; Santelmo N; Hassler S; Schott R; Quoix E; Massard G; Noël G
    Cancer Radiother; 2013; 17(4):272-81. PubMed ID: 23712043
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Stereotactic ablative irradiation for lung cancer].
    Antoni D; Srour I; Noël G; Mornex F
    Cancer Radiother; 2014; 18(4):297-307. PubMed ID: 24907006
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
    Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
    Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stereotactic body radiation therapy for stage I non-small-cell lung cancer: a historical overview of clinical studies.
    Onishi H; Araki T
    Jpn J Clin Oncol; 2013 Apr; 43(4):345-50. PubMed ID: 23436937
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Study of 201 non-small cell lung cancer patients given stereotactic ablative radiation therapy shows local control dependence on dose calculation algorithm.
    Latifi K; Oliver J; Baker R; Dilling TJ; Stevens CW; Kim J; Yue B; Demarco M; Zhang GG; Moros EG; Feygelman V
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1108-13. PubMed ID: 24529716
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pulmonary imaging after stereotactic radiotherapy-does RECIST still apply?
    Mattonen SA; Ward AD; Palma DA
    Br J Radiol; 2016 Sep; 89(1065):20160113. PubMed ID: 27245137
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Imaging of Novel Oncologic Treatments in Lung Cancer Part 2: Local Ablative Therapies.
    Halpenny D; O'Dwyer E; Camacho Vasquez J; Shaverdian N; Girshman J; Ginsberg MS
    J Thorac Imaging; 2020 Jan; 35(1):37-48. PubMed ID: 31592831
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Narcissus, the Beam, and lung cancer.
    Rocco G
    J Thorac Cardiovasc Surg; 2016 Aug; 152(2):338-343.e3. PubMed ID: 27209014
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lung ablation: Best practice/results/response assessment/role alongside other ablative therapies.
    de Baere T; Tselikas L; Gravel G; Deschamps F
    Clin Radiol; 2017 Aug; 72(8):657-664. PubMed ID: 28215455
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Defining the role of radiofrequency ablation and stereotactic ablative radiotherapy in patients with high-risk, early-stage non-small cell lung cancer.
    Louie AV; Siva S; Senan S
    Cancer; 2016 Jan; 122(2):322-3. PubMed ID: 26421800
    [No Abstract]   [Full Text] [Related]  

  • 60. Reply to defining the role of radiofrequency ablation and stereotactic ablative radiotherapy in patients with high-risk, early-stage non-small cell lung cancer.
    Fernando HC; Dupuy DE
    Cancer; 2016 Jan; 122(2):323-4. PubMed ID: 26421899
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.